Antisense Therapeutics – Price Target Raised from $0.305 to $0.43 Staff Writers January 14, 2021 11:24 am
A potential turning point in the battle against COVID-19 Janus Henderson Investors November 11, 2020 12:11 pm
Australian Healthcare: 10 Years In 10 Charts Alphinity Investment Management November 10, 2020 8:47 am